Drug Discovery Outsourcing-United States Market Status and Trend Report 2013-2023
Report Summary
Drug Discovery Outsourcing-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug Discovery Outsourcing industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
United States Drug Discovery Outsourcing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Drug Discovery Outsourcing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Libraries
Building Blocks
Compound Synthesis
Target Validation
United States Drug Discovery Outsourcing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Chemistry Services
Biology Services
Lead Optimisation
Lead Identification and Screening
United States Drug Discovery Outsourcing Market: Players Segment Analysis (Company and Product introduction, Drug Discovery Outsourcing Sales Volume, Revenue, Price and Gross Margin):
Albany Mlecular Research (AMRI)
Aptuit
Charles River Labratries
Cvance
Cyprtex
Dmainex
Evtec
GenScript
Pharmaceutical Prduct Develpment (PPD)
Quintiles
Selcia
Viva Bitech
WIL Research Labratries
WuXi AppTec
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug Discovery Outsourcing-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug Discovery Outsourcing industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Whole United States and Regional Market Size of Drug Discovery Outsourcing 2013-2017, and development forecast 2018-2023
- Main market players of Drug Discovery Outsourcing in United States, with company and product introduction, position in the Drug Discovery Outsourcing market
- Market status and development trend of Drug Discovery Outsourcing by types and applications
- Cost and profit status of Drug Discovery Outsourcing, and marketing status
- Market growth drivers and challenges
United States Drug Discovery Outsourcing Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Drug Discovery Outsourcing Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Libraries
Building Blocks
Compound Synthesis
Target Validation
United States Drug Discovery Outsourcing Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Chemistry Services
Biology Services
Lead Optimisation
Lead Identification and Screening
United States Drug Discovery Outsourcing Market: Players Segment Analysis (Company and Product introduction, Drug Discovery Outsourcing Sales Volume, Revenue, Price and Gross Margin):
Albany Mlecular Research (AMRI)
Aptuit
Charles River Labratries
Cvance
Cyprtex
Dmainex
Evtec
GenScript
Pharmaceutical Prduct Develpment (PPD)
Quintiles
Selcia
Viva Bitech
WIL Research Labratries
WuXi AppTec
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG DISCOVERY OUTSOURCING
1.1 Definition of Drug Discovery Outsourcing in This Report
1.2 Commercial Types of Drug Discovery Outsourcing
1.2.1 Libraries
1.2.2 Building Blocks
1.2.3 Compound Synthesis
1.2.4 Target Validation
1.3 Downstream Application of Drug Discovery Outsourcing
1.3.1 Chemistry Services
1.3.2 Biology Services
1.3.3 Lead Optimisation
1.3.4 Lead Identification and Screening
1.4 Development History of Drug Discovery Outsourcing
1.5 Market Status and Trend of Drug Discovery Outsourcing 2013-2023
1.5.1 United States Drug Discovery Outsourcing Market Status and Trend 2013-2023
1.5.2 Regional Drug Discovery Outsourcing Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug Discovery Outsourcing in United States 2013-2017
2.2 Consumption Market of Drug Discovery Outsourcing in United States by Regions
2.2.1 Consumption Volume of Drug Discovery Outsourcing in United States by Regions
2.2.2 Revenue of Drug Discovery Outsourcing in United States by Regions
2.3 Market Analysis of Drug Discovery Outsourcing in United States by Regions
2.3.1 Market Analysis of Drug Discovery Outsourcing in New England 2013-2017
2.3.2 Market Analysis of Drug Discovery Outsourcing in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Drug Discovery Outsourcing in The Midwest 2013-2017
2.3.4 Market Analysis of Drug Discovery Outsourcing in The West 2013-2017
2.3.5 Market Analysis of Drug Discovery Outsourcing in The South 2013-2017
2.3.6 Market Analysis of Drug Discovery Outsourcing in Southwest 2013-2017
2.4 Market Development Forecast of Drug Discovery Outsourcing in United States 2018-2023
2.4.1 Market Development Forecast of Drug Discovery Outsourcing in United States 2018-2023
2.4.2 Market Development Forecast of Drug Discovery Outsourcing by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Drug Discovery Outsourcing in United States by Types
3.1.2 Revenue of Drug Discovery Outsourcing in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Drug Discovery Outsourcing in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug Discovery Outsourcing in United States by Downstream Industry
4.2 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in New England
4.2.2 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The Midwest
4.2.4 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The West
4.2.5 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The South
4.2.6 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in Southwest
4.3 Market Forecast of Drug Discovery Outsourcing in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG DISCOVERY OUTSOURCING
5.1 United States Economy Situation and Trend Overview
5.2 Drug Discovery Outsourcing Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG DISCOVERY OUTSOURCING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Drug Discovery Outsourcing in United States by Major Players
6.2 Revenue of Drug Discovery Outsourcing in United States by Major Players
6.3 Basic Information of Drug Discovery Outsourcing by Major Players
6.3.1 Headquarters Location and Established Time of Drug Discovery Outsourcing Major Players
6.3.2 Employees and Revenue Level of Drug Discovery Outsourcing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG DISCOVERY OUTSOURCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Albany Mlecular Research (AMRI)
7.1.1 Company profile
7.1.2 Representative Drug Discovery Outsourcing Product
7.1.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Albany Mlecular Research (AMRI)
7.2 Aptuit
7.2.1 Company profile
7.2.2 Representative Drug Discovery Outsourcing Product
7.2.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Aptuit
7.3 Charles River Labratries
7.3.1 Company profile
7.3.2 Representative Drug Discovery Outsourcing Product
7.3.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Charles River Labratries
7.4 Cvance
7.4.1 Company profile
7.4.2 Representative Drug Discovery Outsourcing Product
7.4.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cvance
7.5 Cyprtex
7.5.1 Company profile
7.5.2 Representative Drug Discovery Outsourcing Product
7.5.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cyprtex
7.6 Dmainex
7.6.1 Company profile
7.6.2 Representative Drug Discovery Outsourcing Product
7.6.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Dmainex
7.7 Evtec
7.7.1 Company profile
7.7.2 Representative Drug Discovery Outsourcing Product
7.7.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Evtec
7.8 GenScript
7.8.1 Company profile
7.8.2 Representative Drug Discovery Outsourcing Product
7.8.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of GenScript
7.9 Pharmaceutical Prduct Develpment (PPD)
7.9.1 Company profile
7.9.2 Representative Drug Discovery Outsourcing Product
7.9.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Pharmaceutical Prduct Develpment (PPD)
7.10 Quintiles
7.10.1 Company profile
7.10.2 Representative Drug Discovery Outsourcing Product
7.10.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Quintiles
7.11 Selcia
7.11.1 Company profile
7.11.2 Representative Drug Discovery Outsourcing Product
7.11.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Selcia
7.12 Viva Bitech
7.12.1 Company profile
7.12.2 Representative Drug Discovery Outsourcing Product
7.12.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Viva Bitech
7.13 WIL Research Labratries
7.13.1 Company profile
7.13.2 Representative Drug Discovery Outsourcing Product
7.13.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WIL Research Labratries
7.14 WuXi AppTec
7.14.1 Company profile
7.14.2 Representative Drug Discovery Outsourcing Product
7.14.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WuXi AppTec
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG DISCOVERY OUTSOURCING
8.1 Industry Chain of Drug Discovery Outsourcing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG DISCOVERY OUTSOURCING
9.1 Cost Structure Analysis of Drug Discovery Outsourcing
9.2 Raw Materials Cost Analysis of Drug Discovery Outsourcing
9.3 Labor Cost Analysis of Drug Discovery Outsourcing
9.4 Manufacturing Expenses Analysis of Drug Discovery Outsourcing
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG DISCOVERY OUTSOURCING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Drug Discovery Outsourcing in This Report
1.2 Commercial Types of Drug Discovery Outsourcing
1.2.1 Libraries
1.2.2 Building Blocks
1.2.3 Compound Synthesis
1.2.4 Target Validation
1.3 Downstream Application of Drug Discovery Outsourcing
1.3.1 Chemistry Services
1.3.2 Biology Services
1.3.3 Lead Optimisation
1.3.4 Lead Identification and Screening
1.4 Development History of Drug Discovery Outsourcing
1.5 Market Status and Trend of Drug Discovery Outsourcing 2013-2023
1.5.1 United States Drug Discovery Outsourcing Market Status and Trend 2013-2023
1.5.2 Regional Drug Discovery Outsourcing Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug Discovery Outsourcing in United States 2013-2017
2.2 Consumption Market of Drug Discovery Outsourcing in United States by Regions
2.2.1 Consumption Volume of Drug Discovery Outsourcing in United States by Regions
2.2.2 Revenue of Drug Discovery Outsourcing in United States by Regions
2.3 Market Analysis of Drug Discovery Outsourcing in United States by Regions
2.3.1 Market Analysis of Drug Discovery Outsourcing in New England 2013-2017
2.3.2 Market Analysis of Drug Discovery Outsourcing in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Drug Discovery Outsourcing in The Midwest 2013-2017
2.3.4 Market Analysis of Drug Discovery Outsourcing in The West 2013-2017
2.3.5 Market Analysis of Drug Discovery Outsourcing in The South 2013-2017
2.3.6 Market Analysis of Drug Discovery Outsourcing in Southwest 2013-2017
2.4 Market Development Forecast of Drug Discovery Outsourcing in United States 2018-2023
2.4.1 Market Development Forecast of Drug Discovery Outsourcing in United States 2018-2023
2.4.2 Market Development Forecast of Drug Discovery Outsourcing by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Drug Discovery Outsourcing in United States by Types
3.1.2 Revenue of Drug Discovery Outsourcing in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Drug Discovery Outsourcing in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug Discovery Outsourcing in United States by Downstream Industry
4.2 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in New England
4.2.2 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The Midwest
4.2.4 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The West
4.2.5 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in The South
4.2.6 Demand Volume of Drug Discovery Outsourcing by Downstream Industry in Southwest
4.3 Market Forecast of Drug Discovery Outsourcing in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG DISCOVERY OUTSOURCING
5.1 United States Economy Situation and Trend Overview
5.2 Drug Discovery Outsourcing Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG DISCOVERY OUTSOURCING MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Drug Discovery Outsourcing in United States by Major Players
6.2 Revenue of Drug Discovery Outsourcing in United States by Major Players
6.3 Basic Information of Drug Discovery Outsourcing by Major Players
6.3.1 Headquarters Location and Established Time of Drug Discovery Outsourcing Major Players
6.3.2 Employees and Revenue Level of Drug Discovery Outsourcing Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG DISCOVERY OUTSOURCING MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Albany Mlecular Research (AMRI)
7.1.1 Company profile
7.1.2 Representative Drug Discovery Outsourcing Product
7.1.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Albany Mlecular Research (AMRI)
7.2 Aptuit
7.2.1 Company profile
7.2.2 Representative Drug Discovery Outsourcing Product
7.2.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Aptuit
7.3 Charles River Labratries
7.3.1 Company profile
7.3.2 Representative Drug Discovery Outsourcing Product
7.3.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Charles River Labratries
7.4 Cvance
7.4.1 Company profile
7.4.2 Representative Drug Discovery Outsourcing Product
7.4.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cvance
7.5 Cyprtex
7.5.1 Company profile
7.5.2 Representative Drug Discovery Outsourcing Product
7.5.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Cyprtex
7.6 Dmainex
7.6.1 Company profile
7.6.2 Representative Drug Discovery Outsourcing Product
7.6.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Dmainex
7.7 Evtec
7.7.1 Company profile
7.7.2 Representative Drug Discovery Outsourcing Product
7.7.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Evtec
7.8 GenScript
7.8.1 Company profile
7.8.2 Representative Drug Discovery Outsourcing Product
7.8.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of GenScript
7.9 Pharmaceutical Prduct Develpment (PPD)
7.9.1 Company profile
7.9.2 Representative Drug Discovery Outsourcing Product
7.9.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Pharmaceutical Prduct Develpment (PPD)
7.10 Quintiles
7.10.1 Company profile
7.10.2 Representative Drug Discovery Outsourcing Product
7.10.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Quintiles
7.11 Selcia
7.11.1 Company profile
7.11.2 Representative Drug Discovery Outsourcing Product
7.11.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Selcia
7.12 Viva Bitech
7.12.1 Company profile
7.12.2 Representative Drug Discovery Outsourcing Product
7.12.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of Viva Bitech
7.13 WIL Research Labratries
7.13.1 Company profile
7.13.2 Representative Drug Discovery Outsourcing Product
7.13.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WIL Research Labratries
7.14 WuXi AppTec
7.14.1 Company profile
7.14.2 Representative Drug Discovery Outsourcing Product
7.14.3 Drug Discovery Outsourcing Sales, Revenue, Price and Gross Margin of WuXi AppTec
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG DISCOVERY OUTSOURCING
8.1 Industry Chain of Drug Discovery Outsourcing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG DISCOVERY OUTSOURCING
9.1 Cost Structure Analysis of Drug Discovery Outsourcing
9.2 Raw Materials Cost Analysis of Drug Discovery Outsourcing
9.3 Labor Cost Analysis of Drug Discovery Outsourcing
9.4 Manufacturing Expenses Analysis of Drug Discovery Outsourcing
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG DISCOVERY OUTSOURCING
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
